PRMT5 overexpression competes with β-catenin and PRMT5/AEG-1 interaction frees β-catenin, allowing it to translocate to the nucleus and promote gene expression and HCC [125]. The gene discussed is MTDH; the disease is hepatocellular carcinoma.